Davis Selected Advisers

Institutional investor · Portfolio as of Q2 2026

Top Holdings112 positions

Checking export access…
Activity:
COF

Capital One Financial Corporation

8.3M$1.7B7.1%$73.52+170.09%
30 qtrssince 2019-Q1
Decreased
0
USB

U.S. Bancorp

21.5M$1.3B5.6%$37.05+64.51%
30 qtrssince 2019-Q1
Decreased
0
CVS

CVS Health Corporation

11.9M$1.2B5.3%$46.05+85.12%
30 qtrssince 2019-Q1
Decreased
0
VTRS

Viatris Inc.

75.2M$1.2B5.1%$10.98+86.56%
23 qtrssince 2020-Q4
Decreased
0
MGM

MGM Resorts International

23.9M$1.1B4.9%$37.52-12.30%
12 qtrssince 2023-Q3
Decreased
0
GOOGL

Alphabet Inc.

2.9M$1B4.5%$87.85+228.02%
30 qtrssince 2019-Q1
Decreased
0
DVN

Devon Energy Corporation

25.3M$1B4.5%$41.05+3.28%
1 qtr
New
88
AMZN

Amazon.com, Inc.

4.3M$1B4.4%$128.80+107.25%
30 qtrssince 2019-Q1
Increased
72
META

Meta Platforms, Inc.

1.6M$928.7M4.0%$161.53+297.06%
30 qtrssince 2019-Q1
Decreased
0
MKL

Markel Group Inc.

406,759$794.4M3.4%$1,393.42+40.03%
30 qtrssince 2019-Q1
Increased
62
TXN

Texas Instruments Incorporated

2.4M$726.5M3.1%$104.23+183.74%
30 qtrssince 2019-Q1
Decreased
0
TSN

Tyson Foods, Inc.

12.7M$724.5M3.1%$55.16+8.54%
9 qtrssince 2024-Q2
Decreased
0
WFC

Wells Fargo & Company

8M$661.9M2.8%$36.06+137.05%
30 qtrssince 2019-Q1
Decreased
0
BRK/A

Berkshire Hathaway Inc.

868$650M2.8%——
30 qtrssince 2019-Q1
Decreased
0
CI

The Cigna Group

2.3M$621.2M2.7%$241.08+22.61%
30 qtrssince 2019-Q1
Increased
54
JBS

JBS N.V.

50M$592.7M2.5%$13.58-3.39%
3 qtrssince 2025-Q4
Increased
85
UNH

UnitedHealth Group Incorporated

1.3M$529.8M2.3%$303.48+31.02%
30 qtrssince 2019-Q1
Increased
55
TECK

Teck Resources Ltd

8.4M$497.3M2.1%$28.82+124.39%
20 qtrssince 2021-Q3
Decreased
0
SOLV

Solventum Corporation

6.3M$486.7M2.1%$57.28+57.88%
9 qtrssince 2024-Q2
Decreased
0
LYB

LyondellBasell Industries NV

8.7M$458M2.0%$69.35-14.21%
2 qtrssince 2026-Q1
Increased
70
$23.3B
AUM
112
Positions
Q2 2026
Filing
HI rating · 4.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$17,349,673,9130.832902114824%
2025-Q2$18,702,346,9807.79653308634%
2025-Q3$19,154,485,3652.41754890701%
2025-Q4$22,249,323,81616.1572519022%
2026-Q1$21,781,443,023-2.10289893243%
2026-Q2$23,289,545,4926.92379502776%
Activity profile
$ moved · Q2'26
New18%Increased16%Decreased42%Exited23%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.1 years
<1Q2%1-4Q11%1-2Y11%2Y+77%

Davis Selected Advisers manages $23.3B across 112 positions as of Q2 2026. Top holdings: COF (7.1%), USB (5.6%), CVS (5.3%). Fund DNA: Steady Compounder. HoldingsIntel Score: 4/5.0.

Q2 2026 Summary

Added 2 new positions, exited 2, increased 18, trimmed 87. Top move: DVN (NEW, conviction 88). Portfolio: $23.3B across 112 positions.

Top holdings by portfolio weight

Total AUM$23B
COF7.13%
USB5.56%
CVS5.27%
VTRS5.13%
MGM4.91%
GOOGL4.51%
DVN4.49%
AMZN4.38%
META3.99%
MKL3.41%
Other3.12%

Portfolio allocation by GICS sector

Sectors11
Financial Services29.33%
Healthcare18.85%
Consumer Cyclical12.52%
Communication Services12.02%
Consumer Defensive5.70%
Energy5.33%
Technology5.10%
Basic Materials4.29%
Industrials3.11%
Unknown2.27%
Other1.50%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Financial Services, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L74
Conviction55
Concentration73
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
COPCOPConocoPhillips
Q1 2025 → Q2 2026+506,810 shares+$59.3M
4Q
CICIThe Cigna Group
Q3 2025 → Q2 2026+1.6M shares+$404.4M
4Q
NVDANVDANVIDIA Corporation
Q3 2025 → Q2 2026+65,592 shares+$16.9M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used